Polypharmacy in people with dementia: Associations with adverse health outcomes
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
&NA; Polypharmacy has been linked to higher risks of hospitalisation and death in community samples. It is commonly present in people with dementia but these risks have rarely been studied in this population. We aimed to investigate associations between polypharmacy and emergency department attendance, any and unplanned hospitalisation, and mortality in patients with dementia. Using a large mental health care database in South London, linked to hospitalisation and mortality data, we assembled a retrospective cohort of patients diagnosed with dementia. We ascertained number of medications prescribed at the time of dementia diagnosis and conducted multivariate Cox regression analyses. Of 4668 patients with dementia identified, 1128 (24.2%) were prescribed 4–6 medications and 739 (15.8%) ≥7 medications. Compared to those using 0–3 medications, patients with dementia using 4–6 or ≥7 agents had an increased risk of emergency department attendance (hazard ratio 1.20/1.35), hospitalisation (hazard ratio 1.12/1.32), unplanned hospital admission (hazard ratio 1.12/1.25), and death within two years (hazard ratio 1.29/1.39) after controlling for potential confounders. We found evidence of a dose response relationship with each additional drug at baseline increasing the risk of emergency department attendance and mortality by 5% and hospitalisation by 3%. In conclusion, polypharmacy at dementia diagnosis is associated with a higher risk of adverse health outcomes. Future research is required to elucidate which specific agents underlie this relationship and if reduction of inappropriate prescribing is effective in preventing these outcomes in dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“Given that almost 50 million people have dementia world-wide, with an expected increase of close to 10 million cases every year (Prince et al., 2013), and growing levels of polypharmacy reported (Qato et al.”
Stewart, R., Soremekun, M., Perera, G., Broadbent, M., Callard, F., Denis, M., Hotopf, M., Thornicroft, G., & Lovestone, S. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-51 · Cited by 445
Self-citationMeasurement, Correlates, and Health Outcomes of Medication Adherence Among Seniors
Vik, S. A., Maxwell, C. J., & Hogan, D. B. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d252 · Cited by 403 · cited 1×
“, 2011), reduced adherence (Vik et al., 2004), higher risk of falls (Richardson et al.”
Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem
Parsons, C. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098616670798 · Cited by 113 · cited 4×
“health outcomes in this group (Parsons, 2017), apart from one study of nursing home residents with severe dementia, in whom the prescription of 10 or more medications was associated with a higher mortality risk (Onder et al.”
Influential
Cited by
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Hospitalisation rates and predictors in people with dementia: a systematic review and meta-analysis
Shepherd, H., Livingston, G., Chan, J., & Sommerlad, A. (2019) · BMC Medicine · doi:10.1186/s12916-019-1369-7 · Cited by 232
“Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al.”
BackgroundResultInfluentialSharma, S., Mueller, C., Stewart, R., Veronese, N., Vancampfort, D., Koyanagi, A., Lamb, S. E., Perera, G., & Stubbs, B. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.03.009 · Cited by 72
Self-citationContinuity of GP care for patients with dementia: Impact on prescribing and the health of patients
Delgado, J., Evans, P. H., Gray, D. P., Sidaway-Lee, K., Allan, L., Clare, L., Ballard, C., Masoli, J., Valderas, J. M., & Melzer, D. (2022) · British Journal of General Practice · doi:10.3399/bjgp.2021.0413 · Cited by 70
“30 Specifically, patients in the HQ were less likely to be prescribed benzodiazepines if at risk of falling and drugs likely to cause constipation — drug interactions that increase the risk of delirium.”
Williamson, L. E., Evans, C. J., Cripps, R. L., Leniz, J., Yorganci, E., & Sleeman, K. E. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.06.012 · Cited by 38
Metadata
- Authors
- Mueller, C., Molokhia, M., Perera, G., Veronese, N., Stubbs, B., Shetty, H., Codling, D., Huntley, J., & Stewart, R.
- Venue
- Experimental Gerontology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 106
- Pages
- 240-245
- ISSN
- 0531-5565 (ISSN-L)
- OpenAlex
- W2791513298
- Cited by
- 113
- References
- 4
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polypharmacy in people with dementia: Associations with adverse health outcomes. https://app.cochat.ai/papers/10.1016/j.exger.2018.02.011
- The paper
- Mueller, C., Molokhia, M., Perera, G., Veronese, N., Stubbs, B., Shetty, H., Codling, D., Huntley, J., & Stewart, R. (2018). Polypharmacy in people with dementia: Associations with adverse health outcomes. Experimental Gerontology. https://doi.org/10.1016/j.exger.2018.02.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.